ImageneBio, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImageneBio, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $83.03M.
- ImageneBio, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $13.96M.
- ImageneBio, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $37.42M.
- ImageneBio, Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $131.30M.
- ImageneBio, Inc. stock issued during period, value, new issues for fiscal 2025 was $83.03M, a 494.59% increase from fiscal 2024.
- ImageneBio, Inc. stock issued during period, value, new issues for fiscal 2024 was $13.96M, a 62.68% decline from fiscal 2023.
- ImageneBio, Inc. stock issued during period, value, new issues for fiscal 2023 was $37.42M.
- ImageneBio, Inc. stock issued during period, value, new issues for fiscal 2021 was $131.30M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $83.03M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $83.03M 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $13.96M 10-K · filed 2026-03-10 | |
| 2024-03-31 | $13.96M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $37.42M 10-K · filed 2025-03-06 | |
| 2023-06-30 | $37.42M 10-Q · filed 2024-11-07 | |
| 2021-12-31 | $131.30M 10-K · filed 2023-03-14 | |
| 2021-03-31 | $131.30M 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |